Advertisement
Saturday, July 25
Legal documents and gavel representing a pharmaceutical court filing

Novo Nordisk filed for a U.S. court injunction Friday to immediately block Eli Lilly’s obesity and diabetes drug ads, escalating their pharmaceutical rivalry.

Legal documents and gavel representing a pharmaceutical court filing

Novo Nordisk filed for a U.S. court injunction Friday to immediately block Eli Lilly’s obesity and diabetes drug ads, escalating their pharmaceutical rivalry.